DEA Judge Recommends End to Government Obstruction of Medical Marijuana
For Immediate Release
February 13, 2023

DEA Judge Recommends End to Government Obstruction of Medical Marijuana

Historic Step Toward Nation's First Privately-Funded Marijuana Production

Washington, D.C. - University of Massachusetts-Amherst Professor Lyle
Craker, MAPS, the ACLU, and a broad array of medical and public policy
groups nationwide enthusiastically supported today's official recommendation
by Drug Enforcement Administration (DEA) Administrative Law Judge Mary Ellen
Bittner that Prof. Craker be permitted to grow research-grade marijuana for
use in privately-funded government-approved studies that aim to develop the
marijuana plant into a legal, prescription medicine. Judge Bittner ruled
that it is in the public interest to end the federal government's monopoly,
which it has maintained for over six decades, on the supply of marijuana
that can be used in FDA-approved research.

This ruling is a victory for science, medicine and the public good, said
Prof. Craker. I hope the DEA abides by the decision and grants me the
opportunity to do my job unimpeded by drug war politics.�

The 87-page Opinion and Recommended Ruling by Judge Bittner, who is
appointed by the U.S. Department of Justice, marks a unique window of
opportunity in the six year struggle by MAPS and Prof. Craker to gain a
Schedule I DEA license to grow research-grade marijuana for use by
scientists in MAPS-funded, DEA- and FDA-approved studies.

For decades, politicians have said that marijuana has no proven medical
value while scientists have been denied the ability to prove otherwise,
said Rick Doblin, Ph.D., president and founder of MAPS.

The court's ruling is only a recommendation to DEA Deputy Administrator
Michele Leonhart, however, not a binding ruling; thus, the DEA retains final
decision-making authority. In response, scientists, researchers, doctors and
medical marijuana patients nationwide are joining MAPS and the ACLU by
encouraging the DEA to comply with the court�s finding and to halt federal
obstruction of medical marijuana research.

Prior to this recent ruling, organizations that had already written to DEA
in favor of Prof. Craker's application included the Multiple Sclerosis
Foundation, the Lymphoma Foundation of America, the National Association for
Public Health Policy, the United Methodist Church, Americans for Tax Reform,
the American Medical Students Association, several state nurses'
associations, the Massachusetts Dept. of Public Health, Massachusetts
Senators Kerry and Kennedy, 38 members of the US House of Representatives,
and the California and Texas State Medical Associations, the two largest US
state medical associations.

If the DEA grants Prof. Craker a Schedule I license, his proposed
research-grade medical marijuana production facility will be funded by MAPS,
a non-profit research organization that plans to design, fund, and obtain
government approval for the clinical trials necessary to bring marijuana to
market as a fully legal, prescription medication. MAPS has had two
FDA-approved marijuana studies blocked by NIDA, and would require a
reliable, high-quality supply of research material to justify the time and
expense to sponsor FDA-approved clinical research evaluating the risks and
benefits of marijuana as a potential FDA-approved medicine.

The ACLU and the Washington D.C. law firm Jenner & Block, LLP are co-counsel
for the case and are assisted by Steptoe & Johnson, LLP.

For extensive background information on Professor Craker's proposed medical
marijuana production facility, please see:

# # #

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a
membership-based non-profit research and educational organization that
assists scientists to design, fund, obtain approval for and report on
studies into the risks and benefits of MDMA, psychedelic drugs and
marijuana. MAPS' mission is to sponsor scientific research designed to
develop psychedelics and marijuana into FDA-approved prescription medicines,
and to educate the public honestly about the risks and benefits of these
c4cadmin op Monday 12 February 2023 - 21:50:09
Read/Post Comment: 0
email to someone  printer friendly   create pdf of this news item

 US president orders military to begin jailing all civilian protestors to war
In yet another shocking prelude towards becoming a Total Police State, Russian Intelligence Analysts are reporting today that the American War Leaders have issued orders to the United States Military Northern Command authorizing the jailing, and military tribunals, for any American citizen critical of the 'war effort'.

These reports state that the American President has 'lost his confidence' in the American Judicial System and has further ordered his War Cabinet to begin attacking civilian judges, and as we can read as confirmed by the MSNBC News Service in their article titled "Gonzales: Judges unfit to rule on terror policy", and which says:

"Attorney General Alberto Gonzales says federal judges are unqualified to make rulings affecting national security policy, ramping up his criticism of how they handle terrorism cases.

"We want to determine whether he understands the inherent limits that make an unelected judiciary inferior to Congress or the president in making policy judgments," Gonzales says in the prepared speech. "That, for example, a judge will never be in the best position to know what is in the national security interests of our country."

Read more

Gonzales: Judges unfit to rule on terror policy
Attorney general says federal jurists should defer to president's will
c4cadmin op Saturday 03 February 2023 - 10:19:21
Read/Post Comment: 0
email to someone  printer friendly   create pdf of this news item

 Life Insurance for Responsible Cannabis Users

NORML Announces Life Insurance Coverage For Responsible Cannabis Smokers

Washington, DC: The National Organization for the Reform of Marijuana Laws (NORML), the nation's oldest and most respected cannabis-law reform organization, today announced that life insurance is finally available for adult cannabis consumers.

NORML has partnered with The McLaughlin Company and a pair of nationally recognized insurance providers to offer life insurance products to responsible cannabis consumers. Previously, adults who self-reported using cannabis �-- even in moderate amounts --� were denied life insurance coverage or, at best, offered coverage at a grossly inflated premium. Starting today, cannabis consumers will have access to the same types of life insurance plans as non-users, and they will no longer be forced to pay excessively high premiums.

"Unlike cigarettes or even alcohol, moderate use of cannabis --� even when used long-term �-- is not shown to have significant negative ramifications on health or mortality," ** NORML Executive Director Allen St. Pierre said. "As a result, responsible cannabis consumers should not be forced to pay inflated premiums or be denied insurance coverage because of their marijuana use."

NORML and its partners hope to expand its life insurance program to offer cannabis-friendly disability and health insurance products later this year.

For more information, please contact NORML Executive Director Allen St. Pierre at (202) 483-5500 or visit:

To listen to an audio message about the NORML Life Insurance program from The McLaughlin Company's Webb Hubbell, please visit:

** D. Vinson. 2006. Marijuana and other illicit drug use and the risk of injury: A case-control study. Missouri Medicine 103: 152-156 | R. Blondell et al. 2005. Toxicology screening results: injury associations among hospitalized trauma patients. Journal of TRAUMA Injury, Infection, and Critical Care 58: 561-570 | S. Sidney et al. 1997. Marijuana Use and Mortality. American Journal of Public Health 87: 1-4 | Editorial: "Deglamorising Cannabis." The Lancet, Nov. 11, 1995. (346:8985).

c4cadmin op Saturday 20 January 2023 - 21:25:12
Read/Post Comment: 0
email to someone  printer friendly   create pdf of this news item

Go to page   <<        >>  

c4cadmin @ (21 Dec : 22:41) (misc)

All trademarks are � their respective owners, all other content is � e107 powered website.
e107 is � 2002/2003 and is released under the GNU GPL license.
Render time: 0.3397 second(s); 0.1603 of that for queries.